Full title: Inter-Ewings: International clinical research programme to improve outcomes in newly diagnosed Ewing sarcoma – Trial 1 (INTER-EWING-1)
Age: 2+
Locations:
- Aberdeen – Royal Aberdeen Children’s Hospital
- Birmingham – Birmingham Children’s Hospital, Queen Elizabeth Hospital
- Cambridge – Addenbrooke’s Hospital
- Leeds – St James University Hospital, Leeds General Infirmary
- London – University College London
- Liverpool – Alder Hey Hospital, Clatterbridge Cancer Centre
- Manchester – Christie Hospital, Royal Manchester Children’s Hospital
- Newcastle – Freeman Hospital, Royal Victoria Infirmary
- Sheffield – Sheffield Children’s Hospital, Weston Park Hospital
Brief summary:
INTER-EWING-1 is an international clinical trial examining several new treatment strategies for Ewing sarcoma patient, including access to a novel agent (a multi tyrosine kinase inhibitor- regorafenib), optimising radiotherapy doses and evaluating the effect of “maintenance” chemotherapy at the end of treatment.
To find out more about this trial and whether you could take part, talk to your clinical team.
